Inventor · Beijing, CN

Xiaohong Song

36Patents
14h-index
69Co-inventors
84Inventor score

Filing activity: Dec 12, 2002 → Oct 7, 2022

Most-cited inventions

PatentTitleAreaCited byStatus
US6831175B2 Kinase inhibitors Chemistry; Metallurgy 174 Expired
US7767684B2 Apoptosis promoters Chemistry; Metallurgy 87 Active
US8563735B2 Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases Chemistry; Metallurgy 70 Active
US7642260B2 Apoptosis promoters Chemistry; Metallurgy 60 Active
US8546399B2 Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases Emerging Cross-Sectional Technologies 57 Active
US8586754B2 BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases Chemistry; Metallurgy 55 Active
US7973161B2 Apoptosis promoters Chemistry; Metallurgy 50 Active
US8426422B2 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases Chemistry; Metallurgy 47 Active
US8173811B2 Apoptosis promoters Chemistry; Metallurgy 42 Active
US8084607B2 Apoptosis promoters Chemistry; Metallurgy 37 Active
US8614318B2 Apoptosis promoters Chemistry; Metallurgy 35 Active
US8354404B2 Apoptosis promoters Chemistry; Metallurgy 33 Active
US8686136B2 Apoptosis promoters Chemistry; Metallurgy 17 Active
US9174982B2 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases Emerging Cross-Sectional Technologies 15 Active
US9045444B2 Apoptosis promoters Chemistry; Metallurgy 9 Active
US9303025B2 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases Emerging Cross-Sectional Technologies 9 Active
US9072748B2 BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases Chemistry; Metallurgy 9 Active
US9125913B2 Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases Chemistry; Metallurgy 8 Active
US8940737B2 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases Chemistry; Metallurgy 7 Active
US8445679B2 7-substituted indole MCL-1 inhibitors Chemistry; Metallurgy 6 Active
US7981888B2 1-oxyalkyl-2-carboxyl-7-nonsubstituted indole derivatives Chemistry; Metallurgy 6 Active
US8889675B2 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases Chemistry; Metallurgy 3 Active
US9227963B2 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases Chemistry; Metallurgy 2 Active
US9266877B2 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases Chemistry; Metallurgy 2 Active
US8853209B2 1-oxyalkyl-2-carboxy-7-nonsubstituted indole derivatives Chemistry; Metallurgy 2 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.